Cervical Cancer Vaccine

Journal of Pediatric and Adolescent Gynecology

Volumn 19, Issue 6, 2006, Pages 423-424

  Nicoletti, Angela ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNIZATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; VIRUS STRAIN;

ATTITUDE TO HEALTH; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 33845464698     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2006.09.010     Document Type: Article

References (2)

1. FDA.gov FDA News: FDA licenses new vaccine for the prevention of cervical cancer and other diseases in females caused by the Human Papillomavirus. P06-77, June 8, 2006. Available at: http://www.fda.gov/cder/offices/OODP/whatsnew/gardasil.htm. Accessed August 15, 2006.
2. CDC Media Relations: CDC's advisory committee recommends Human Papillomavirus virus vaccination. Press Release, June 29, 2006. Available: http://www.cdc.gov/od/oc/media/pressrel/r060629.htm. 2006. Accessed August 15, 2006.